Last reviewed · How we verify
Not for treatment of diabetic ketoacidosis
Approved treatments
- Prandin · Novo Nordisk
Repaglinide lowers blood glucose levels by stimulating insulin release from the pancreas through ATP-dependent potassium channel blockade.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Not for treatment of diabetic ketoacidosis patent landscape — cliff calendar, originator estates, attackable patents
- Not for treatment of diabetic ketoacidosis treatment landscape brief
- Not for treatment of diabetic ketoacidosis treatment updates RSS
Frequently asked questions about Not for treatment of diabetic ketoacidosis
What drugs treat Not for treatment of diabetic ketoacidosis?
Tracked treatments include Prandin.
What is the treatment for Not for treatment of diabetic ketoacidosis?
Standard treatment for Not for treatment of diabetic ketoacidosis includes Prandin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Not for treatment of diabetic ketoacidosis patent cliff · Not for treatment of diabetic ketoacidosis CI report
- Treatment: Prandin · Novo Nordisk
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing